• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰变加速因子(DAF)与细胞膜上的C4b和C3b的内源性结合。

Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes.

作者信息

Kinoshita T, Medof M E, Nussenzweig V

出版信息

J Immunol. 1986 May 1;136(9):3390-5.

PMID:2420889
Abstract

Decay-accelerating factor (DAF) is a membrane glycoprotein found on various cells that are in contact with complement. It inhibits the formation of the C3 convertases of the complement system, both the classic (C4b2a) and alternative (C3bBb) pathways. In this investigation, we used a homobifunctional cross-linking reagent to search for a DAF ligand on the surface of cells subjected to complement attack. We found that DAF forms complexes with C4b and C3b deposited on the same erythrocytes, but not with the physiologic degradation products of these complement fragments, that is, C4d or C3dg. Taken together with prior observations that DAF action is reversible, and DAF does not affect the structure of C4b or C3b, these findings suggest that DAF functions by competitively inhibiting the uptake of C2 or factor B, and preventing the assembly of the C3 convertases.

摘要

衰变加速因子(DAF)是一种在与补体接触的各种细胞上发现的膜糖蛋白。它抑制补体系统经典途径(C4b2a)和替代途径(C3bBb)中C3转化酶的形成。在本研究中,我们使用同双功能交联剂在遭受补体攻击的细胞表面寻找DAF配体。我们发现DAF与沉积在同一红细胞上的C4b和C3b形成复合物,但不与这些补体片段的生理性降解产物即C4d或C3dg形成复合物。结合先前关于DAF作用是可逆的且DAF不影响C4b或C3b结构的观察结果,这些发现表明DAF通过竞争性抑制C2或B因子的摄取以及阻止C3转化酶的组装来发挥作用。

相似文献

1
Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes.衰变加速因子(DAF)与细胞膜上的C4b和C3b的内源性结合。
J Immunol. 1986 May 1;136(9):3390-5.
2
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.衰变加速因子(DAF)整合到细胞膜后对细胞表面补体激活的抑制作用。
J Exp Med. 1984 Nov 1;160(5):1558-78. doi: 10.1084/jem.160.5.1558.
3
The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.衰变加速因子(DAF)的作用机制。DAF通过解离C2a和Bb来抑制C3转化酶的组装。
J Exp Med. 1987 Nov 1;166(5):1221-8. doi: 10.1084/jem.166.5.1221.
4
Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.经典途径激活的表面调节:绵羊、豚鼠和人红细胞上C2和C3转化酶的形成与调节
J Immunol. 1983 Jul;131(1):403-8.
5
Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.补体调节蛋白衰变加速因子(DAF)、补体受体1(CR1)和H因子在C3转化酶上结合位点的差异。
J Immunol. 1986 Mar 15;136(6):2216-21.
6
The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.膜成分对衰变加速因子调节替代途径激活的影响。
J Immunol. 1990 Dec 1;145(11):3836-41.
7
Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.衰变加速因子在存在C4或C3肾炎因子的情况下对经典途径和替代途径C3转化酶组装的影响。
Immunology. 1989 Dec;68(4):449-52.
8
Membrane-bound C4b interacts endogenously with complement receptor CR1 of human red cells.膜结合的C4b在体内与人红细胞的补体受体CR1相互作用。
J Exp Med. 1986 Nov 1;164(5):1377-88. doi: 10.1084/jem.164.5.1377.
9
Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.表达裂解C3的膜蛋白酶p65的人黑色素瘤细胞补体抗性的分子基础
Cancer Res. 1993 Feb 1;53(3):592-9.
10
Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.一种杂交补体调节蛋白——中国仓鼠卵巢细胞膜辅因子蛋白衰变加速因子的表达。其调节作用与衰变加速因子和膜辅因子蛋白调节作用的比较。
J Immunol. 1994 Apr 1;152(7):3436-44.

引用本文的文献

1
CRISPR-Cas9 screening reveals a distinct class of MHC-I binders with precise HLA-peptide recognition.CRISPR-Cas9筛选揭示了一类具有精确HLA-肽识别能力的独特MHC-I结合物。
iScience. 2024 May 27;27(6):110120. doi: 10.1016/j.isci.2024.110120. eCollection 2024 Jun 21.
2
CD55 in cancer: Complementing functions in a non-canonical manner.CD55 在癌症中的作用:以非规范方式发挥补体功能。
Cancer Lett. 2022 Dec 28;551:215935. doi: 10.1016/j.canlet.2022.215935. Epub 2022 Oct 7.
3
Pegcetacoplan in paroxysmal nocturnal hemoglobinuria: A systematic review on efficacy and safety.
培格西他单抗治疗阵发性夜间血红蛋白尿:疗效与安全性的系统评价
Res Pract Thromb Haemost. 2022 Aug 7;6(5):e12781. doi: 10.1002/rth2.12781. eCollection 2022 Jul.
4
Aspects of the Complement System in New Era of Xenotransplantation.补体系统在新时代异种移植中的作用
Front Immunol. 2022 Apr 14;13:860165. doi: 10.3389/fimmu.2022.860165. eCollection 2022.
5
Complement in Tumourigenesis and the Response to Cancer Therapy.补体在肿瘤发生及癌症治疗反应中的作用
Cancers (Basel). 2021 Mar 10;13(6):1209. doi: 10.3390/cancers13061209.
6
The interaction between the complement system and hemostatic factors.补体系统与止血因子的相互作用。
Curr Opin Hematol. 2020 Sep;27(5):341-352. doi: 10.1097/MOH.0000000000000605.
7
C3b deposition on human erythrocytes induces the formation of a membrane skeleton-linked protein complex.补体3b(C3b)在人红细胞上的沉积诱导了一种膜骨架连接蛋白复合物的形成。
J Clin Invest. 2009 Apr;119(4):788-801. doi: 10.1172/JCI36088. Epub 2009 Mar 2.
8
Adenovirus type 11 uses CD46 as a cellular receptor.11型腺病毒将CD46用作细胞受体。
J Virol. 2003 Sep;77(17):9183-91. doi: 10.1128/jvi.77.17.9183-9191.2003.
9
Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi.克氏锥虫补体调节蛋白的膜结合形式和可溶性形式的生化分析。
Infect Immun. 1994 Jan;62(1):236-43. doi: 10.1128/iai.62.1.236-243.1994.
10
Membrane proteins that protect against complement lysis.防止补体溶解的膜蛋白。
Springer Semin Immunopathol. 1994;15(4):369-96. doi: 10.1007/BF01837366.